The miR-17-92 cluster as a whole has recently been shown to drive cancer development by supressing the expression of inhibitors of the PI3K and NFkB pathways, thereby activating these pathways and promoting cell cycle progression, survival and migration [13]. This evidence concerns the gene NFKB1 and cancer.